Viral Hepatitis C - SciClone Reports Results from First ZADAXIN Phase 3

SciClone Reports Results from First ZADAXIN Phase 3
Pharma Live - SAN MATEO, Calif. -- December 14, 2005 -- SciClone Pharmaceuticals, Inc. ( with pegylated interferon alpha to treat patients with

Do Type and Duration of Antiretroviral Therapy Reduce the Severity of Liver Disease in HIVHCV Coinfected Patie
HIV and Hepatitis.com - is turning to care for individuals living with HIV who are coinfected with

EU scientists seek big investment in nanomedicine
ABCNEWS.com - to carry tumor-killing agents into cells, while